tirzepatide and semaglutide therapeutic modality Ozempic® (semaglutide) Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Assessing the Safety of Semaglutide

2021 Oct 26;11(5):517-525." Accessed on April 3, 2024, at The BMJ - "Long term health consequences of obesity." Accessed on April 3, 2024, at American Pharmacists Association (APhA) - "Compounding FAQs." Accessed on April 3, 2024, at Centers for Disease Control and Prevention (CDC) - "How Overweight and Obesity Impacts Your Health." Accessed on June 18, 2024, at CDC - "Consequences of Obesity." Accessed on April 3, 2024, at Drugs.com - "Tirzepatide User Reviews for Diabetes, Type 2." Accessed on April 3, 2024, at National Academies Press (NAP) - "Drug Compounding: An Interactive Learning Experience." Accessed on April 3, 2024, at Accreditation Commission for Health Care (ACHC) - "Pharmacy Compounding Accreditation." Accessed on April 3, 2024, at Accreditation Council for Pharmacy Education (ACPE) - "ACPE - Continuing Pharmacy Education." Accessed on April 3, 2024, at PubMed Central (PMC) - "BMJ Open

I will begin Month 2 after next week

That number might seem modest compared to the higher tiers, but context matters

Gentle Physical Activity to Aid Digestion Exercise might sound counterintuitive when youre feeling nauseous

They are provided to help interpret the literature, not as a protocol for human use